In vitro modulation of human, autoreactive MBP-specific CD4 + T-cell clones by cyclosporin A

Journal of Neuroimmunology

Volumn 76, Issue 1-2, 1997, Pages 91-99

  Pette, Martin ^a   Pette, Dagmar F ^a   Muraro, Paolo A ^a   Martin, Roland ^a   McFarland, Henry F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cyclosporin A; In vitro; Multiple sclerosis; T lymphocytes

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYCLOSPORINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MYELIN BASIC PROTEINS;

EID: 0030917263     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00035-0     Document Type: Article

References (48)

1. Antel, J.P., Williams, K., Blain, M., McRea, E. and McLaurin, J. (1994) Oligodendrocyte lysis by CD4+ T-cells independent of tumor necrosis factor. Ann. Neurol. 35, 341-348.
2. Bach, J.F. (1993) Immunosuppressive therapy of autoimmune diseases. Trends. Pharmacol. Sci. 14, 213-216.
3. Begley, D.J., Squires, L.K., Zlokovic, B.W., Mitrovic, D.M., Hughes, C.C.W., Revest, P.A. and Greenwood, J. (1990) Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J. Neurochem. 55, 1222-1230.
4. Belsito, D.V., Epstein, S.P., Schultz, J.M., Baer, R.L. and Thorbecke, G.J. (1989) Enhancement by various cytokines or 2-beta-mercaptoethanol of Ia antigen expression on Langerhans cells in skin from normal aged and young mice. Effect of cyclosporine A. J. Immunol. 143, 1530-1536.
5. Bolton, C., Allsopp, G. and Cuzner, M.L. (1982a) The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin. Exp. Immunol. 47, 127-132.
6. Bolton, C., Borel, J.F., Cuzner, M.L., Davison, A.N. and Turner, A.M. (1982b) Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis. J. Neurol. Sci. 56, 147-153.
7. Boussiotis, V.A., Nadler, L.M., Strominger, J.L. and Goldfeld, A.E. (1994) Tumor necrosis factor alpha is an autocrine growth factor for normal human B-cells. Proc. Natl. Acad. Sci. USA 91, 7007-7011.
8. Brosnan, C.F. and Raine, C.S. (1996) Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6, 243-257.
9. Chiara, M.D. and Sobrino, F. (1991) Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: Effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology 72, 133-137.
10. Cirillo, R., Triggiani, M., Siri, L., Ciccarelli, A., Pettit, G.R., Condorelli, M. and Marone, G. (1990) Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J. Immunol. 144, 3891-3897.
11. Dos Reis, G.A. and Shevach, E.M. (1982) Effect of cyclosporin A on T-cell function in vitro: The mechanism of suppression of T-cell proliferation depends on the nature of the T-cell stimulus as well as the differentiation state of the responding T-cell. J. Immunol. 129, 2360-2367.
12. Dutz, J.P., Fruman, D.A., Burakoff, S.J. and Bierer, B.E. (1993) A role for calcineurin in degranulation of murine cytotoxic T-lymphocytes. J. Immunol. 150, 2591-2598.
13. Elliott, J.F., Lin, Y., Mizel, S.B., Bleackley, R.C., Harnish, D.G. and Paetkau, V. (1984) Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 226, 1439-1441.
14. Emmel, E.A., Verweij, C.L., Durand, D.B., Higgins, K.M., Lacy, E. and Crabtree, G.R. (1989) Cyclosporin A specifically inhibits function of nuclear proteins involved in T-cell activation. Science 246, 1617-1620.
15. Espevik, T., Figari, I.S., Shalaby, M.R., Lackides, G.A., Lewis, G.D., Shepard, H.M. and Palladino, M.A., Jr. (1987) Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166, 571-576.
16. Esser, M.T., Krishnamurthy, B. and Braciale, V.L. (1996) Distinct T-cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity. J. Exp. Med. 183, 1697-1706.
17. Feutren, G. and von Graffenried, B. (1992) Cyclosporin A. Pharmacology and therapeutic use in autoimmune diseases. In: H.E. Rugstad, L. Endresen and F. Oeystein (Eds.), Immunopharmacology in Autoimmune Diseases and Transplantation. Plenum Press, New York, pp. 159-173.
18. Fruman, D.A., Burakoff, S.J. and Bierer, B.E. (1994) Molecular actions of cyclosporin A, FK506 and rapamycin. In: A.W. Thomson and T.E. Starzl (Eds.), Immunosuppressive Drugs. Developments in Anti-rejection Therapy. Edward Arnold, London, pp. 15-35.
19. Gepner, P., Amor, B. and Fournier, C. (1989) 1,25-dihydroxyvitamin D3 potentiates the in vitro inhibitory effects of cyclosporin A on T-cells from rheumatoid arthritis patients. Arthritis. Rheum. 32, 31-36.
20. Jaraquemada, D., Martin, R., Rosen-Bronson, S., Flerlage, M., McFarland, H.F. and Long, E.O. (1990) HLA-DR2a is the dominant restriction molecule for the cytotoxic T-cell response to myelin basic protein in DR2Dw2 individuals. J. Immunol. 145, 2880-2885.
21. Kappos, L., Patzold, U., Dommasch, D., Poser, S., Haas, J., Krauseneck, P., Malin, J.P., Fierz, W., Graffenried, B.U. and Gugerli, U.S. (1988) Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis-results of the German multicenter study. Ann. Neurol. 23, 56-63.
22. Karmann, K., Pober, J.S. and Hughes, C.C. (1994) Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T-cells requires contact-dependent interactions involving CD2 but not CD28. J. Immunol. 153, 3929-3937.
23. Karpus, W.J., Lukacs, N.W., McRae, B.L., Strieter, R.M., Kunkel, S.L. and Miller, S.D. (1996) An important role for the chemokine macrophage inflammatory protein-1alpha in the pathogenesis of the T-cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155, 5003-5010.
24. Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S. and Nagai, K. (1996) Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-based and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156, 3678-3686.
25. Lancki, D.W., Kaper, B.P. and Fitch, F.W. (1989) The requirements for triggering of lysis by cytolytic T-lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL. J. Immunol. 142, 416-424.
26. Li, B., Sehajpal, P.K., Subramaniam, A., Joseph, A., Stenzel, K.H. and Suthanthiran, M. (1992) Inhibition of interleukin 2 receptor expression in normal human T-cells by cyclosporine. Demonstration at the mRNA, protein and functional levels. Transplantation 53, 146-151.
27. Lin, J.X., Migone, T.S., Tsang, M., Friedmann, M., Weatherbee, J.A., Zhou, L., Yamauchi, A., Bloom, E.T., Mietz, J., John, S. and Leonard, W.J. (1995) The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2, 331-339.
28. Martin, D.F., DeBarge, L.R., Nussenblatt, R.B., Chan, C.C. and Roberge, F.G. (1995) Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis. J. Immunol. 154, 922-927.
29. Martin, R., Jaraquemada, D., Flerlage, M., Richert, J., Whitaker, J.N., Long, E.O., McFarlin, D.E. and McFarland, H.F. (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T-cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145, 540-548.
30. Martin, R. and McFarland, H.F. (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32, 121-182.
31. McCaffrey, P.G., Goldfeld, A.E. and Rao, A. (1994) The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. J. Biol. Chem. 269, 30445-30450.
32. Miyawaki, T., Yachie, A., Ohzeki, S., Nagaoki, T. and Taniguchi, N. (1983) Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T-cells. J. Immunol. 130, 2737-2742.
33. Nguyen, D.T., Eskandai, M.K., DeForge, L.E., Raiford, C.L., Strieter, R.M., Kunkel, S.L. and Remick, D.G. (1990) Cyclosporin a modulation of tumor necrosis factor gene expression and effects in vitro and in vivo. J. Immunol. 144, 3822-3828.
34. Niederberger, W., Lemaire, M., Maurer, G., Nussbaumer, K. and Wagner, O. (1983) Distribution and binding of cyclosporine in blood and tissues. Transplant. Proc. 15, 2419-2422.
35. Paavonen, T. and Hayry, P. (1980) Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature 287, 542-544.
36. Palestine, A.G., Muellenberg-Coulombre, C.G., Kim, M.K., Gelato, M.C. and Nussenblatt, R.B. (1987) Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. J. Clin. Invest. 79, 1078-1081.
37. Paul, C. and Bolton, C. (1995) Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int. J. Immunopharmacol. 17, 497-503.
38. Pette, M., Fujita, K., Kitze, B., Whitaker, J.N., Albert, E., Kappos, L. and Wekerle, H. (1990) Myelin basic protein-specific T-lymphocyte lines from MS patients and healthy individuals. Neurology 40, 1770-1776.
39. Reed, J.C., Abidi, A.H., Alpers, J.D., Hoover, R.G., Robb, R.J. and Nowell, P.C. (1986) Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J. Immunol. 137, 150-154.
40. Rudge, P., Koetsier, J.C., Mertin, J., Mispelblom-Beyer, J.O., van Walbeek, H.K., Clifford-Jones, R., Harrison, J., Robinson, K., Mellein, A., Poole, T., Stokvis, J.C.J.M. and Timonen, P. (1989) Randomised double blind controlled trial of cyclosporin in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 52, 559-565.
41. Ryffel, B., Willcocks, J.L., Brooks, N. and Woerly, G. (1995) Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: Sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. Immunopharmacology 30, 199-207.
42. Sawada, S., Suzuki, G., Kawase, Y. and Takaku, F. (1987) Novel immunosuppressive agent, FK506. In vitro effects on the cloned T-cell activation. J. Immunol. 139, 1797-1803.
43. Schall, T.J. (1994) The chemokines. In: A.W. Thomson (Ed.), The Cytokine Handbook. Academic Press, London, pp. 419-460.
44. Smith, K.A. (1995) Cell growth signal transduction is quantal. Ann. N. Y. Acad. Sci. 263-271.
45. Smith, M.E., Stone, L.A., Frank, J.A., Albert, P., Maloni, H., Naveau, I., Porter, J., Armstrong, M., McFarlin, D.E. and McFarland, H.F. (1993) MRI used to monitor efficacy of early treatment of R/R MS. Neurology 43, A183 (abstr).
46. The Multiple Sclerosis Study Group, (1990) Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial. Ann. Neurol. 27, 591-605.
47. Utz, U., Banks, D., Jacobson, S. and Biddison, W.E. (1996) Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type I (HTLV-1) Tax-specific CD8+ cytotoxic T-lymphocytes from patients with HTLV-1-associated disease. J. Virol. 70, 843-851.
48. Weiss, D.L., Hural, J., Tara, D., Timmerman, L.A., Henkel, G. and Brown, M.A. (1996) Nuclear factor of activated T-cells is associated with a mast cell interleukin 4 transcription complex. Mol. Cell. Biol. 16, 228-235.